Illumina, headquartered in San Diego, develops life science tools for genetic analysis, employing 10,590 staff since its IPO in 2000. Its products span various applications, including oncology and agriculture.
Scott M Davies sold 1,336 shares of ILMN on 20 February at $116.18 per share, worth a total of $155K. They now own 16,334 ILMN shares, or a 8% holding decrease.
📡️ Health Care
Insider Trades
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.